Ranjit S. Bindra, MD, PhD
Yale University School of Medicine
Small Molecule Screening for Novel Rhabdoid Tumor Inhibitors
Dr. Ranjit S. Bindra is an Assistant Professor of Therapeutic Radiology at Yale University. He earned his Ph.D. in experimental pathology and M.D. from Yale University School of Medicine. Dr. Bindra completed his residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. He is a recipient of the Marie Curie Award.
What is Dr. Bindra currently researching?
Small Molecule Screening for Novel Rhabdoid Tumor Inhibitors: “Atypical Teratoid/Rhabdoid Tumors (ATRTs) are rare, but highly aggressive and resistant brain tumors which affect infants and toddlers. Despite aggressive surgery, multi-agent chemotherapy and intensive radiation therapy regimens, patients often recur at the site where the tumor was initially found. These findings have led researchers to test whether novel drugs can be developed, which can be either used alone or combined with radiation therapy and chemotherapy, in order to prevent these tumors from recurring at the original site. My research will screen to identify these novel agents.” – Dr. Bindra
This grant is funded by the Nikhil Kondagari Foundation Fund for Rhabdoid Tumor Research.